Superlymph 25U suppositories 10pcs

In the complex treatment of herpetic diseases of the urogenital tract, including those complicated by bacterial and other viral infections.
In the complex treatment of chronic recurrent uncomplicated cystitis to prolong the period of remission.

Superlymph® is an immunomodulator, a natural complex of natural antimicrobial peptides and cytokines - universal stimulants of the immune system with the activity of a factor inhibiting the migration of macrophages, interleukin 1 (IL-1), IL-6, tumor necrosis factor (TNF), transforming growth factor secreted by leukocytes of the peripheral blood of a pig.
It has antiviral, antimicrobial and antifungal effects. The drug stimulates the functional activity of phagocytic cells (monocytes and neutrophils): activates phagocytosis, cytokine production (IL-1, TNF), induces antitumor cytotoxicity of macrophages, regulates cell migration to the site of inflammation, increases the activity of natural killers. The drug has antioxidant activity, reduces the development of inflammatory reactions, stimulates regeneration and epithelialization of wound defects.

For the treatment of viral infections in the acute stage, Superlymph® 10 U/25 U is used vaginally or rectally depending on the patient's gender, if necessary, alternating the route of administration, Superlymph® 25 U, 1 suppository once a day or Superlymph® 10 U, 1 suppository 2 times a day, morning and evening. The course duration is from 10 to 20 days.
To prevent relapse of viral infection, use Superlymph®
10 U, 1 suppository once a day, possibly alternating rectal and vaginal administration.
Duration of the course is 10 days.
In order to prevent possible relapses, repeated courses are allowed sequentially or after 1-2 months.

In the complex therapy of chronic recurrent uncomplicated cystitis, to extend the period of remission, Superlymph® 25 U is used rectally, 1 suppository once a day for 10 days. The course of therapy with Superlymph® 25 U begins simultaneously with antibacterial and symptomatic therapy for an episode of cystitis in patients.

Contraindications
Body temperature above 38 °C;
Hypersensitivity to proteins of porcine origin and excipients;
History of severe allergic reactions;
Malignant neoplasms in the active stage;
Breastfeeding period.
Age under 18 years (due to lack of data on efficacy and safety)